TickerFacts.

Charles River Laboratories International, Inc. (CRL): Long-Term Debt

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-27 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2018-12-29, while the company's latest annual report covers the year ended 2025-12-27. Its later filings do not report this line under the concept TickerFacts maps.

$1.61B
As of 2018-12-29
+25.5%
3-year compound annual growth
2010-12-25: $700.75M2011-12-31: $717.90M2012-12-29: $666.45M2013-12-28: $663.05M2014-12-27: $716.63M2015-12-26: $814.24M2016-12-31: $1.18B2017-12-30: $1.09B2018-12-29: $1.61B$1.61B
2010-12-25 Long-Term Debt (USD) 2018-12-29
Period endedLong-Term DebtChange YoYSource filing
2018-12-29$1.61B+48.3%2019-02-13, Balance as of period end
2017-12-30$1.09B-8.0%2019-02-13, Balance as of period end
2016-12-31$1.18B+45.0%2018-02-13, Balance as of period end
2015-12-26$814.24M+13.6%2017-02-14, Balance as of period end
2014-12-27$716.63Mn/c2016-02-12, Balance as of period end
2013-12-28$663.05M-0.5%2015-02-17, Balance as of period end
2012-12-29$666.45M-7.2%2014-02-25, Balance as of period end
2011-12-31$717.90M+2.4%2013-02-27, Balance as of period end
2010-12-25$700.75Mn/a2012-02-27, Balance as of period end